Thursday, July 9, 2026

pharma · Endometrial Cancer · XBIO

Xenetic Biosciences

Xenetic Biosciences patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Framingham, USA HQ
7 Employees
Public company Type
XBIO · NYSE Ticker
Company details
Status
Public
HQ
Framingham, USA
Employees
7
Programs
1
Drugs
1
Patents
1
Intelligence · Patents

Xenetic Biosciences patents

1 pharmaceutical patents indexed for Xenetic Biosciences. 0 expire within 24 months.

Xenetic Biosciences has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 10188739

    Compositions and methods for administering insulin or insulin-like protein to the brain

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Xenetic Biosciences have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Xenetic Biosciences patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.